Group B Streptococcus (GBS) urinary tract infection involves binding of GBS to bladder uroepithelium and potent but GBS-specific induction of interleukin 1alpha.
Group B Streptococcus (GBS) causes urinary tract infections, but the pathogenic mechanisms underlying GBS urinary tract infections are unknown. We investigated whether uropathogenic GBS can bind to bladder uroepithelium to initiate urinary tract infection. Uropathogenic GBS isolated from a patient with acute cystitis bound to human T24 bladder uroepithelial cells in close association with F-actin in statistically significantly higher numbers compared with nonuropathogenic GBS. In vivo modeling using transurethrally infected mice revealed superior fitness of uropathogenic GBS for bladder colonization and potent uropathogenic GBS-specific up-regulation of interleukin 1alpha during infection. Thus, binding of uropathogenic GBS to uroepithelium and vigorous induction of interleukin 1alpha represents the initial stages of GBS urinary tract infection.
Departments of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA. g.ulett@griffith.edu.au
Glen C
GC
Ulett
Richard I
RI
Webb
Kimberly B
KB
Ulett
Xiangqin
X
Cui
William H
WH
Benjamin
Michael
M
Crowley
Mark A
MA
Schembri
D000328:Adult; D000818:Animals; D004797:Enzyme-Linked Immunosorbent Assay; D004848:Epithelium / Q000382:microbiology; D005260:Female; D006801:Humans; D053582:Interleukin-1alpha / Q000096:biosynthesis* / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D018613:Microscopy, Confocal; D008855:Microscopy, Electron, Scanning; D008875:Middle Aged; D013290:Streptococcal Infections / Q000276:immunology / Q000382:microbiology*; D013292:Streptococcus agalactiae / Q000472:pathogenicity*; D001743:Urinary Bladder / Q000382:microbiology* / Q000473:pathology; D014552:Urinary Tract Infections / Q000276:immunology / Q000382:microbiology*; D014556:Urine / Q000382:microbiology
D053582:Interleukin-1alpha